Caregiver Expressed Emotion, Quality of Life and Medication Adherence among People Living with Schizophrenia in Nigeria

Babandi F; Usman UM; Habib ZG; Owolabi DS; Gudaji MI; Taura AA; Aghukwa CN; Baguda AS; Salihu AS*

Babandi F, Usman UM, Habib ZG, Owolabi DS, Gudaji MI, Taura AA, Aghukwa CN, Baguda AS and Salihu AS*

Volume3-Issue5
Dates: Received: 2022-05-19 | Accepted: 2022-05-24 | Published: 2022-05-25
Pages: 627-633

Abstract

Background: People Living with Schizophrenia (PLWS) are expected to live longer than before the advent of psychotropic drugs. Relationship of Caregiver Expressed Emotion and Medication Adherence to Quality of Life in African PLWS is not known. The aim of the study was to determine the relationship between the levels of caregiver expressed emotion, quality of life and medication adherence among people living with schizophrenia.

Method: Data were collected on Socio-demographic and Schizophrenia Clinical Characteristic, Quality of Life, Caregiver Expressed Emotion (EE) and Medication adherence using Socio-demographic and Schizophrenia Clinical Characteristics questionnaire, World Health Organization Quality of Life (WHOQoL) - Brief, Caregiver Level of EE scale and Morisky Medication Adherence Scale (MMAS) respectively.

Results: Caregiver EE was significantly associated with the physical and environmental domains of QoL (p = 0.011 and p = 0.001 respectively). Poor medication adherence correlated positively with the negative attitude and low tolerance sub-scales of the level of EE scale (p = 0.019 and p < 0.001). Medication adherence related significantly to the overall, health-related and physical domains of QoL (p < 0.001, p = 0.017 and p = 0.031). Medication adherence was also a positive predictor of overall QoL (p < 0.001).

Conclusion: The High EE has been found to be closely related to the patients’ QoL. The role of medication adherence in promoting QoL among PLWS has been re-emphasized by the findings.

FullText HTML FullText PDF DOI: 10.37871/jbres1489

Certificate of Publication

Copyright

How to cite this article

Babandi F, Usman UM, Habib ZG, Owolabi DS, Gudaji MI, Taura AA, Aghukwa CN, Baguda AS, Salihu AS. Caregiver Expressed Emotion, Quality of Life and Medication Adherence among People Living with Schizophrenia in Nigeria. J Biomed Res Environ Sci. 2022 May 25; 3(5): 627-633. doi: 10.37871/jbres1489, Article ID: JBRES1489, Available at: https://www.jelsciences.com/articles/jbres1489.pdf

Subject area(s)

Mental Health

Psychiatry

References

Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning? Int J Ment Health Syst. 2010 Dec 8;4:31. doi: 10.1186/1752-4458-4-31. PMID: 21143871; PMCID: PMC3016370.
Hooley JM, Gotlib IH. A diathesis-stress conceptualization of expressed emotion and clinical outcome. Appl Prev Psychol. 2000;9:135-51. doi: 10.1016/S0962-1849(05)80001-0.
Boyer L, Millier A, Perthame E, Aballea S, Auquier P, Toumi M. Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry. 2013 Jan 9;13:15. doi: 10.1186/1471-244X-13-15. PMID: 23302219; PMCID: PMC3544732.
Mahaye S, Mayima T, Nkosi S, Mahomed FN, Ntuli L, Pramal J, Setibana O, Oosthuizan F. Medication adherence of psychiatric patients in an outpatient setting. Afr J Pharm. 2012;6(9):608-12. doi: 10.5897/AJPP11.646.
Barbato A. World health organization division of mental health and prevention of substance abuse. Schizophrenia and Public Health. 1998;1-32. https://tinyurl.com/4z8c27ay
Mohd S, Christoday RJK, Srearlj S, Uvais NA. Medication adherence in schizophrenia: A hospital-based cross-sectional study of family-related factor. Psychiatr Rehabil J. 2017;4(2):215-219. doi: 10.1007/s40737-017-0093-x.
Aloba O, Fatoye O, Mapayi B, Akinsulore S. A review of Quality of Life studies in Nigerian patients with psychiatric disorders. Afr J Psychiatry (Johannesbg). 2013 Sep;16(5):333-7. doi: 10.4314/ajpsy.v16i5.44. PMID: 24051665.
Christian E. Case studies of family expressed emotion for families of patients living with schizophrenia in delta state of Nigeria. Eur J of Mental Health. 2009;4(2):247-256. doi: 10.1556/EJMH.4.2009.2.5.
Ibrahim AW, Pindar SK, Yerima MM, Rabbebe IB, Shehu S, Garkuwa HA, Bashir, IY, Wakil MA, Yahya SJ. Medication related factors of non-adherence among patients with schizophrenia and bipolar disorder. Outcome of a cross-sectional survey in maiduguri, North eastern Nigeria. J Neurosci Behav Health. 2015;7(5):31-39. doi: 10.5897/JNBH2015.0128.
Ayilara O, Ogunwale A, Babalola E. Perceived expressed emotions in relatives of patients with severe mental illness: A comparative study. Psychiatry Res. 2017 Nov;257:137-143. doi: 10.1016/j.psychres.2017.07.037. Epub 2017 Jul 20. PMID: 28755604.
Reicher B, Adeyemi JD, Lawal RA, Famuyiwa OO, Haruna AY, Jibodu MO. Emotional reactions of relatives to schizophrenic patients in Lagos, Nigeria. Afr J Med Med Sci. 2003 Mar;32(1):7-11. PMID: 15030058.
Ogbolu RE, Adeyemi JD, Erinfolami AR. Expressed emotion among schizophrenic patients in Lagos, Nigeria: a pilot study. Afr J Psychiatry (Johannesbg). 2013 Sep;16(5):329, 331. doi: 10.4314/ajpsy.v16i5.43. PMID: 24051664.
Hashemi AH, Cochrane R. Expressed emotion and schizophrenia: a review across cultures. Int Rev Psychiatry. 1999;11:219-224. doi: 10.1080/09540269974401.
Kurihara T, Kato M, Tsukahara T, Takano Y, Reverger R. The low prevalence of high levels of expressed emotion in Bali. Psychiatry Res. 2000 Jul 17;94(3):229-38. doi: 10.1016/s0165-1781(00)00143-8. PMID: 10889287.
Abioda DI, Morakinyo O, Ibrahim A. Quality of life in persons with schizophrenia in North-Western Nigeria. The IJPSY. 2013;2(1). https://tinyurl.com/35fprnze
Adewuya AO, Makanjuola RO. Subjective life satisfaction and objective life conditions of people with schizophrenia in South Western Nigeria. Psychiatr Times. 2016;61(3):314-316. doi: 10.1176/appi.ps.61.3.314.
Ogunnubi OP, Olagunju AT, Aina OF, Okubadejo NU. Medication Adherence Among Nigerians with Schizophrenia: Correlation Between Clinico-Demographic Factors and Quality of Life. Ment Illn. 2017 Mar 22;9(1):6889. doi: 10.4081/mi.2017.6889. PMID: 28479972; PMCID: PMC5379219.
Effiong JH, Umoh KA. Medication non-adherence in schizophrenia: Prevalence, correlates among out patients in a tertiary health facility in Uyo, South-South Nigeria. J Clin Med. 2015;5(6):107-113. doi: 10.5923/j.cmd.20150506.01.
Sellwood W, Tarrier N, Quinn J, Barrowclough C. The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion. Psychol Med. 2003 Jan;33(1):91-6. doi: 10.1017/s0033291702006888. PMID: 12537040.
Hayhurst KP, Drake RJ, Massie JA, Dunn G, Barnes TR, Jones PB, Lewis SW. Improved quality of life over one year is associated with improved adherence in patients with schizophrenia. Eur Psychiatry. 2014 Mar;29(3):191-6. doi: 10.1016/j.eurpsy.2013.03.002. Epub 2013 Jun 12. PMID: 23769325.